Abacavir + Lamivudine + Zidovudine

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
Abacavir 300mg / Lamivudine 150mg / Zidovudine 300mg tabletsES GB300 mg / 150 mgViiv Healthcare B.V.
abacavir + lamivudina + zidovudinaES150 mg / 300 mgViiv Healthcare B.V.
ABACAVIR, LAMIVUDINE AND ZIDOVUDINEUS
  • tablet Abacavir 300 mg + Lamivudine 150 mg + Zidovudine 300 mg
Lupin Pharmaceuticals, Inc.
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINECA
  • tablet Abacavir 300 mg + Lamivudine 150 mg + Zidovudine 300 mg
APOTEX INC
ABACAVIR/LAMIVUDINE/ZIDOVUDINE VIATRIS 300 mg/150 mg/300 mg, comprimé pelliculéFR
  • tablet Abacavir + Lamivudine 150 mg + Zidovudine 300 mg
VIATRIS SANTE
TRIZIVIR 300 mg / 150 mg / 300 mg, comprimé pelliculéFR
  • tablet Abacavir 351 mg + Lamivudine 150 mg + Zidovudine 300 mg
VIIV HEALTHCARE (PAYS-BAS)

Same combination in other markets

No product with this combination is recorded in the other covered markets yet.

Only the main ingredient is the same — this is NOT the same fixed-dose combination. View the main ingredient

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.